Dianabol vs Anadrol: What’s the Difference?

Roids Questions Team

Few gym debates run longer than Dianabol versus Anadrol. Both are old-school oral anabolic steroids with decades of reputation behind them — and a surprising amount of that reputation comes from dosing artefacts and bro-science. We put the two side by side: where they came from, how they actually work, and what genuinely separates them on strength, gyno risk, liver strain and mood.

What are Dianabol and Anadrol, and why were they originally developed?

Dianabol (methandrostenolone) arrived in the 1950s. It was developed as an orally active testosterone derivative, with medical use preceding its later spread through sport. It became one of the first anabolic steroids to gain a major reputation for athletic performance, but that was not its original purpose.

Anadrol (oxymetholone) has a genuinely medical origin. It was developed at the end of the 1950s as a medical treatment for anaemia because it strongly stimulates red blood cell production. Clinically, it was used in aplastic anaemia and myelofibrosis, and later investigated for conditions such as myasthenia gravis and HIV-related wasting.

What they share matters as much as what divides them. Both are oral 17α-alkylated anabolic-androgenic steroids. That label means a methyl group is attached at the 17-alpha position of the molecule — a tweak that lets the compound survive digestion and the liver’s first-pass metabolism, so it works as a pill. The same tweak is also why both place stress on the liver, as we’ll get to below.

Both are also controlled substances in most jurisdictions — prescription-only or illegal to possess without one. That medical and legal framing shapes everything else in this comparison. If you want a broader look at where these two sit within the full range of anabolic compounds, the main site keeps a detailed breakdown by compound class.

How do Dianabol and Anadrol work differently in the body?

Both compounds bind the androgen receptor and increase protein synthesis and nitrogen retention. The pharmacological fork in the road is estrogen.

Dianabol aromatises. The aromatase enzyme converts part of it into methylestradiol, a potent oestrogen. That single fact drives much of Dianabol’s side-effect profile — water retention, rising blood pressure and gynecomastia — and, importantly, how users attempt to manage it.

Anadrol does not aromatise. Its structure is derived from dihydrotestosterone, which aromatase cannot act on. Yet Anadrol can produce oestrogenic effects: bloating, water retention and gyno. The paradox is not fully settled. Proposed explanations include direct activity at the oestrogen receptor by oxymetholone or its metabolites, along with a possible progestogenic pathway. Either way, the signal is not coming from aromatisation.

On paper, the classic animal assays credit Dianabol with an anabolic-to-androgenic ratio around 90–210 to 40–60, and Anadrol around 320 to 45. Treat those numbers as rough — they come from rodent tissue, not human muscle. What they suggest is that both lean strongly anabolic, with Anadrol further out on that axis.

The mechanism difference has a direct practical consequence. An aromatase inhibitor, such as anastrozole, lowers the oestrogen Dianabol produces at the source. Against Anadrol’s oestrogenic effects, the same drug does little because there is no aromatisation to block. Managing the two compounds requires different tools, and neither approach guarantees that gyno will reverse once established.

Which compound is stronger — Anadrol or Dianabol milligram for milligram?

Anadrol’s fearsome reputation rests on a simple artefact: the tablet. Standard Anadrol comes in 50 mg tabs; standard Dianabol in 10 mg. People compare one pill with one pill and conclude that Anadrol is five times the drug. It isn’t — they’re comparing 50 mg with 10 mg.

Milligram for milligram, what does the data show? Less than you’d hope, honestly — there are no clean head-to-head human trials at matched doses. Decades of practical experience suggest that Dianabol is at least comparable per milligram, and many users find 30 mg of Dianabol roughly matches 50 mg of Anadrol for strength and fullness. Anadrol at its common 50–100 mg/day simply delivers more milligrams.

The character of the gains also differs. Oxymetholone produces famously fast scale weight — 5–10 kg in the first two to four weeks is commonly reported — but a large share of that is water and glycogen, not contractile tissue. Dianabol’s gains come on more steadily with moderate water retention, and a bigger share of what remains afterwards tends to be actual muscle — that’s reported experience, not trial data. We have a separate piece on how different oral steroids split their effects between strength output and actual muscle size.

Then there’s the placebo problem. In a 1972 study, Ariel and Saville gave experienced lifters what they believed was Dianabol but was actually a placebo — and the placebo group gained strength at a rate comparable to those on the real compound. The study doesn’t show that Dianabol does nothing; it shows that expectation is powerful, and that rigorous measurement of Dianabol’s true effect size in trained humans is thin on the ground.

The takeaway: dose context, diet and individual response matter more than any compound ranking.

Can Anadrol cause gynecomastia, and how does its gyno risk compare to Dianabol?

Yes — Anadrol can cause gynecomastia, and this confuses people precisely because it doesn’t aromatise. The gyno is real; the pathway is different.

With Dianabol, the chain is straightforward: aromatase converts the compound to oestrogen, oestrogen stimulates breast tissue, and an aromatase inhibitor can interrupt the chain at step one. In practice, users who run Dianabol often keep anastrozole on hand — 0.5 mg once or twice a week is a typical practice range — adjusted to symptoms and bloodwork. That does not make an AI a guaranteed solution, particularly if a firm lump has already formed.

With Anadrol, that lever does not exist. Since no aromatisation happens, an AI has nothing to inhibit — the oestrogenic signal comes from the compound itself or its metabolites acting at the receptor. Management shifts downstream: a SERM such as tamoxifen, which blocks oestrogen at breast tissue directly, is the standard practical tool, typically 10–20 mg/day at the first signs. Early treatment may limit progression, but it cannot be relied on to reverse established glandular tissue.

Which compound is riskier? Both sit in the higher-gyno tier among orals. Reported experience tends to rate Anadrol’s oestrogenic load at least as heavy as Dianabol’s, with the added frustration that it is harder to control. Dianabol’s gyno risk is high but may be more manageable; Anadrol’s is high and often stubborn.

Whichever compound is in question, the early signs are the same: itching, tenderness or a small lump under the nipple. Acting early gives you the best chance of limiting the problem. For a closer look at how anabolic steroids trigger gynecomastia and why the mechanism differs between aromatising and non-aromatising compounds, we covered it in a separate article.

What does each steroid do to the liver, and which is harder on hepatic function?

Both compounds are 17α-alkylated, and that structural feature is exactly why both are hepatotoxic. The 17-alpha methyl group stops the liver from breaking the molecule down efficiently on the first pass — good for oral bioavailability, bad for liver cells. The typical result is elevated ALT and AST, and with heavier exposure, cholestatic stress.

Anadrol carries the harsher reputation, and its medical record shows why. Oxymetholone was prescribed for anaemia at doses of 1–5 mg/kg/day for months at a time; enzyme elevations were common, and long-term use was linked in the medical literature to peliosis hepatis (blood-filled cysts in the liver) and rare hepatic tumours. Those are high-dose, long-duration clinical cases — but they map the outer edge of the risk.

Dianabol elevates liver enzymes too. At typical practice doses (20–50 mg/day for 4–6 weeks), it is generally described as somewhat milder than Anadrol at its typical doses (50–100 mg/day) — but “milder” is relative. Both are among the more liver-stressing compounds in common use precisely because they are oral.

Dose and duration drive much of the risk here. Four to six weeks is the standard practice window for either compound; pushing past eight weeks, escalating the dose or stacking the two orals increases the stress rather than adding to it.

Monitoring is directly relevant if either compound is in use: a baseline liver panel before starting, ALT/AST with bilirubin around weeks two to three, and a recheck after the course. If ALT or AST climbs past roughly three times the upper limit of normal, the practical response is to stop and reassess, not push through.

How do Dianabol and Anadrol differ in mood and psychological effects?

Here’s a difference you won’t find in any assay: how the two compounds feel.

Dianabol is often reported to produce an elevated mood, a sense of wellbeing and strong training drive — sometimes described as mild euphoria. Among oral AAS, that feel-good reputation is one of Dianabol’s signature traits, but it is a user-reported pattern rather than a predictable pharmacological effect.

Anadrol’s mood profile is far less consistent. Reports range from neutral to flat affect, irritability and lethargy, and headaches and appetite suppression come up often enough to matter — an odd trait for a compound used to gain mass.

Why the difference? It may trace back to their distinct chemistry: Dianabol’s conversion to methylestradiol and its particular activity profile versus Anadrol’s non-aromatising, DHT-derived structure. But no controlled work has pinned the mechanism down, so treat this as a pattern in user reports, not an established pathway.

The practical significance is simple: mood response is individual. The compound that looks better on paper may be the one that makes you feel worse in week three.

What is the bottom line — how do Dianabol and Anadrol actually differ for someone comparing the two?

Here’s the whole comparison in one view:

	Dianabol	Anadrol
Generic name	Methandrostenolone	Oxymetholone
Original purpose	Orally active testosterone derivative; later used for athletic performance	Medical treatment of anaemia and blood disorders
Aromatises to oestrogen	Yes — via aromatase	No — but oestrogenic effects still occur
Anabolic:androgenic ratio (animal assays)	~90–210 : 40–60	~320 : 45
Typical dose in practice	20–50 mg/day	50–100 mg/day
Typical course length	4–6 weeks	4–6 weeks
Gains profile	Steady strength and mass, moderate water retention	Rapid scale weight, large water/glycogen share
Gyno risk	High; aromatase inhibitors may help with the aromatisation component	High, and AIs do not help — SERMs are used instead
Liver strain	Hepatotoxic (17α-alkylated)	Hepatotoxic, with the harsher reputation at typical doses
Mood effect	Often reported as a mood lift and increased drive	Variable — lethargy and irritability reported

Neither compound is universally “better” — they involve different trade-offs. Dianabol’s distinguishing package is aromatisation, with the management tools that come with it, steady gains, a somewhat milder per-dose liver load and a mood lift that many users report. Anadrol’s is raw speed of scale weight, no aromatisation but stubborn oestrogenic effects, a harsher hepatic reputation and a less predictable mood profile.

What we won’t do is tell you which one is right — that’s a framing this site avoids on purpose. The honest answer is that the two compounds reward different priorities and punish different mistakes. If you want to go deeper, we’ve written separately about what steroid potency actually measures and why milligram-for-milligram comparisons between compounds can mislead.